• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.09% Nasdaq Up 0.30%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    81.24 Down 0.55(0.67%) Jul 28, 4:00PM EDT
    |After Hours : 81.02 Down 0.22 (0.27%) Jul 28, 7:38PM EDT
    Prev Close:81.79
    Open:81.90
    Bid:81.01 x 400
    Ask:81.40 x 200
    1y Target Est:106.35
    Beta:1.21468
    Earnings Date:Oct 25 - Oct 31 (Est.)
    Day's Range:80.62 - 81.98
    52wk Range:77.92 - 120.37
    Volume:13,010,978
    Avg Vol (3m):10,212,500
    Market Cap:108.13B
    P/E (ttm):7.13
    EPS (ttm):11.39
    Div & Yield:1.88 (2.12%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 0.67%108.13B
    GSKUp 0.13%109.74B
    PFEDown 0.49%222.40B

    Key Statistics

    Forward P/E (1 yr):6.91
    P/S (ttm):3.36
    Ex-Dividend Date:14-Jun-16

    Analysts

    Annual EPS Est (Dec-16) :11.79
    Quarterly EPS Est (Sep-16) :2.88
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):86.75

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback